How to standardize the diagnostic approach to pituitary neuroendocrine tumors
Sofia Asioli(University of Turin), Chiara Villa(Centre National de la Recherche Scientifique), Diego Mazzatenta(Istituto delle Scienze Neurologiche di Bologna), Matteo Zoli(Institute of Neurological Sciences), Federica Guaraldi(Istituto delle Scienze Neurologiche di Bologna)
Cited by 4
Related Papers
Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line<i>AIP</i>Mutations and Pituitary Adenomas: An International Collaborative Study
|The Journal of Clinical Endocrinology & Metabolism|2010|374
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
|Endocrine Related Cancer|2017|357
Gigantism and Acromegaly Due to Xq26 Microduplications and <i>GPR101</i> Mutation
|New England Journal of Medicine|2014|340
Pangenomic Classification of Pituitary Neuroendocrine Tumors
|Cancer Cell|2019|335
The 2016 World Health Organization classification of tumours of the central nervous system
|La Presse Médicale|2018|319